Download FREE Report Sample
Download Free sampleTrastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor.
Trastuzumab Biosimilar Market contains market size and forecasts of Trastuzumab Biosimilar in global, including the following market information:
Global Trastuzumab Biosimilar Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Trastuzumab Biosimilar Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Trastuzumab Biosimilar companies in 2021 (%)
The global Trastuzumab Biosimilar market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adjuvant Breast Cancer Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Trastuzumab Biosimilar include Amgen Inc., Pfizer Inc, Samsung Bioepis, Merck & Co., Biocon Limited, Teva Pharmaceutical, Genentech, Mundipharma and Celltrion and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Trastuzumab Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Trastuzumab Biosimilar Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Trastuzumab Biosimilar Market Segment Percentages, by Type, 2021 (%)
Adjuvant Breast Cancer
Metastatic Breast Cancer
Metastatic Gastric Cancer
Others
Global Trastuzumab Biosimilar Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Trastuzumab Biosimilar Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Online Pharmacy
Global Trastuzumab Biosimilar Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Trastuzumab Biosimilar Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Trastuzumab Biosimilar revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Trastuzumab Biosimilar revenues share in global market, 2021 (%)
Key companies Trastuzumab Biosimilar sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Trastuzumab Biosimilar sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen Inc.
Pfizer Inc
Samsung Bioepis
Merck & Co.
Biocon Limited
Teva Pharmaceutical
Genentech
Mundipharma
Celltrion
Henlius
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
